ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT

ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will combine isogenic ...
Ventura County Star

NovaRhythm Obtains Global Rights from Sanofi for SAR-297871 to Advance Precision Atrial Fibrillation Therapy

A highly selective TASK-1 inhibitor designed to restore rhythm and rate with improved safety — moving toward First-in-Human studies OCALA, FL, UNITED STATES, April ...
Frontiers

Kidney-targeted drug delivery: from physiological mechanisms to precision therapeutics

Chronic kidney disease (CKD) and acute kidney injury (AKI) remain critical global health challenges, yet effective pharmacotherapies are severely limited by poor renal bioavailability and off-target ...
Fort Collins Coloradoan

Precision Quantomics Awarded ~$0.5M from HSSA to Advance Drug Development Innovation and Create Jobs in Spokane County

HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane SPOKANE, WA, UNITED STATES, March 31, 2026 ...